BANVT.E — Banvit Bandirma Vitaminli Yem Sanayi AS Balance Sheet
0.000.00%
- TRY17.95bn
- TRY14.48bn
- TRY31.53bn
Annual balance sheet for Banvit Bandirma Vitaminli Yem Sanayi AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 497 | 753 | 815 | 1,727 | 5,246 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 360 | 570 | 1,448 | 2,565 | 2,491 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,906 | 3,015 | 7,051 | 9,321 | 12,648 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 666 | 755 | 4,625 | 6,318 | 6,118 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,669 | 3,812 | 12,200 | 15,782 | 18,810 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,131 | 2,164 | 7,047 | 8,152 | 7,767 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,665 | 2,568 | 8,198 | 9,428 | 8,805 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,004 | 1,244 | 4,001 | 6,355 | 10,004 |
| Total Liabilities & Shareholders' Equity | 2,669 | 3,812 | 12,200 | 15,782 | 18,810 |
| Total Common Shares Outstanding |